Shares of Molbio Diagnostics rallied up to 6% to Rs 1,044 on Monday after a strong Dalal Street debut, listing at a 21% premium to its IPO price. The stock opened at Rs 980 on both the BSE and NSE, compared with the issue price of Rs 807.
The strong debut surpassed grey market expectations, which had indicated a listing premium of around 15%.